Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1983 Apr;40(1):172–176. doi: 10.1128/iai.40.1.172-176.1983

Human Interferon-γ Enhances the Expression of Class I and Class II Major Histocompatibility Complex Products in Neoplastic Cells More Effectively than Interferon-α and Interferon-β

Antonina Dolei 1,2, Maria R Capobianchi 1, Franco Ameglio 3
PMCID: PMC264832  PMID: 6299957

Abstract

Human interferon-γ was more effective than interferon-β or -α in stimulating production of immunoassociated antigens; HLA-A, -B, and -C; and β2-microglobulin in human M14 and Namalva cells. The comparison was made on the basis of antiviral units, and the stimulation could be abolished by treatment of the interferon-γ preparation with pH 2 or anti-interferon-γ serum.

Full text

PDF
172

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Appella E., Tanigaki N., Fairwell T., Pressman D. Partial amino acid sequences of the heavy chains of human HLS histocompatibility antigens. Biochem Biophys Res Commun. 1976 Jul 12;71(1):286–292. doi: 10.1016/0006-291x(76)90280-1. [DOI] [PubMed] [Google Scholar]
  2. Blalock J. E., Georgiades J. A., Langford M. P., Johnson H. M. Purified human immune interferon has more potent anticellular activity than fibroblast or leukocyte interferon. Cell Immunol. 1980 Feb;49(2):390–394. doi: 10.1016/0008-8749(80)90041-6. [DOI] [PubMed] [Google Scholar]
  3. De Ley M., Van Damme J., Billiau A., De Somer P. The preparation of antibodies directed against human immune interferon. J Virol Methods. 1981 Oct;3(3):149–153. doi: 10.1016/0166-0934(81)90049-5. [DOI] [PubMed] [Google Scholar]
  4. Dianzani F., Monahan T. M., Scupham A., Zucca M. Enzymatic induction of interferon production by galactose oxidase treatment of human lymphoid cells. Infect Immun. 1979 Dec;26(3):879–882. doi: 10.1128/iai.26.3.879-882.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dianzani F., Zucca M., Scupham A., Georgiades J. A. Immune and virus-induced interferons may activate cells by different derepressional mechanisms. Nature. 1980 Jan 24;283(5745):400–402. doi: 10.1038/283400a0. [DOI] [PubMed] [Google Scholar]
  6. Emerson S. G., Murphy D. B., Cone R. E. Selective turnover and shedding of H-2K and H-2D antigens is controlled by the major histocompatibility complex. Implications for H-2-restricted recognition. J Exp Med. 1980 Oct 1;152(4):783–795. doi: 10.1084/jem.152.4.783. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fellous M., Bono R., Hyafil F., Gresser I. Interferon enhances the amount of membrane-bound beta2-microglobulin and its release from human Burkitt cells. Eur J Immunol. 1981 Jun;11(6):524–526. doi: 10.1002/eji.1830110616. [DOI] [PubMed] [Google Scholar]
  8. Fleischmann W. R., Jr Potentiation of the direct anticellular activity of mouse interferons: mutual synergism and interferon concentration dependence. Cancer Res. 1982 Mar;42(3):869–875. [PubMed] [Google Scholar]
  9. Georgiades J. A. Production and purification of the human interferon gamma (HuIFN-gamma). Tex Rep Biol Med. 1981;41:179–183. [PubMed] [Google Scholar]
  10. Heron I., Hokland M., Berg K. Enhanced expression of beta2-microglobulin and HLA antigens on human lymphoid cells by interferon. Proc Natl Acad Sci U S A. 1978 Dec;75(12):6215–6219. doi: 10.1073/pnas.75.12.6215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Imai K., Ng A. K., Glassy M. C., Ferrone S. Differential effect of interferon on the expression of tumor-associated antigens and histocompatibility antigens on human melanoma cells: relationship to susceptibility to immune lysis mediated by monoclonal antibodies. J Immunol. 1981 Aug;127(2):505–509. [PubMed] [Google Scholar]
  12. Jones P. P., Murphy D. B., McDevitt H. O. Variable synthesis and expression of E alpha and Ae (E beta) Ia polypeptide chains in mice of different H-2 haplotypes. Immunogenetics. 1981;12(3-4):321–337. doi: 10.1007/BF01561674. [DOI] [PubMed] [Google Scholar]
  13. Langman R. E., Cohn M. Why the MHC is important to the immune system. Transplant Proc. 1981 Dec;13(4):1797–1799. [PubMed] [Google Scholar]
  14. Lonai P., Steinman L. Physiological regulation of antigen binding to T cells: role of a soluble macrophage factor and of interferon. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5662–5666. doi: 10.1073/pnas.74.12.5662. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Nakamuro K., Tanigaki N., Kreiter V. P., Pressman D. Common antigenic structures of HL-A antigens. IV. HL-A common portion fragment isolated from spent culture medium of human lymphoid cell lines. Immunology. 1974 Dec;27(6):1127–1139. [PMC free article] [PubMed] [Google Scholar]
  16. Nakamuro K., Tanigaki N., Pressman Common antigenic structures of HL-A antigens. VI. Common antigenic determinants located on the 33,000 Dalton alloantigenic fragment portion of papain-solubilized HL-A molecules. Immunology. 1975 Dec;29(6):1119–1132. [PMC free article] [PubMed] [Google Scholar]
  17. Rossi G. B., Dolei A., Capobianchi M. R., Peschle C., Affabris E. Interactions of interferon with in vitro model systems involved in hematopoietic cell differentiation. Ann N Y Acad Sci. 1980;350:279–293. doi: 10.1111/j.1749-6632.1980.tb20628.x. [DOI] [PubMed] [Google Scholar]
  18. Rossi G. B., Dolei A., Cioè L., Peschle C. Effect of interferon on erythropoietic differentiation. Tex Rep Biol Med. 1981;41:381–387. [PubMed] [Google Scholar]
  19. Rubin B. Y., Gupta S. L. Differential efficacies of human type I and type II interferons as antiviral and antiproliferative agents. Proc Natl Acad Sci U S A. 1980 Oct;77(10):5928–5932. doi: 10.1073/pnas.77.10.5928. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Sonnenfeld G., Meruelo D., McDevitt H. O., Merigan T. C. Effect of type I and type II interferons on murine thymocyte surface antigen expression: induction or selection? Cell Immunol. 1981 Jan 15;57(2):427–439. doi: 10.1016/0008-8749(81)90101-5. [DOI] [PubMed] [Google Scholar]
  21. Tanigaki N., Tosi R., Pressman D., Ferrara G. B. Molecular identification of human Ia antigens coded for by a gene locus closely linked to HLA-DR locus. Immunogenetics. 1980;10(2):151–167. doi: 10.1007/BF01561564. [DOI] [PubMed] [Google Scholar]
  22. Tosi R., Tanigaki N., Centis D., Ferrara G. B., Pressman D. Immunological dissection of human Ia molecules. J Exp Med. 1978 Dec 1;148(6):1592–1611. doi: 10.1084/jem.148.6.1592. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Tosi R., Tanigaki N., Centis D., Rossi P. L., Alfano G., Ferrara G. B., Pressman D. HLA-DR typing by radioimmunoassay. Transplantation. 1980 Apr;29(4):302–305. doi: 10.1097/00007890-198004000-00008. [DOI] [PubMed] [Google Scholar]
  24. Yip Y. K., Pang R. H., Urban C., Vilcek J. Partial purification and characterization of human gamma (immune) interferon. Proc Natl Acad Sci U S A. 1981 Mar;78(3):1601–1605. doi: 10.1073/pnas.78.3.1601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Zinkernagel R. M., Doherty P. C. H-2 compatability requirement for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus. Different cytotoxic T-cell specificities are associated with structures coded for in H-2K or H-2D;. J Exp Med. 1975 Jun 1;141(6):1427–1436. doi: 10.1084/jem.141.6.1427. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES